Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

How Microbiotica Developed MB097, Live Bacterial Therapeutic that Could Boost Cancer Treatments

Ghaith Bakdash described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.

Ghaith Bakdash, Director Cell Biology at Microbiotica, during the Microbiome Connect: Europe 2022 described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy